Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Endomagnetics is pinpointed as a future star business

Endomagnetics : 19 November, 2012  (Company News)
The Real Business Future 50 project selects Endomagnetics, the company developing a portfolio of products to improve the standard of breast cancer management, as one of the UK's most exciting, high-potential new businesses.

The Future 50 companies were unveiled at a ceremony at the British Library Conference Centre in London, organized by Real Business in conjunction with The programme was launched in 2011, and identifies, celebrates and supports young companies that are triggering change in their markets, or creating new markets.


Endomagnetics was founded by Simon Hattersley, Audrius Brazdeikis and Quentin Pankhurst to develop nanomagnetic technology as an alternative to the radioisotopes currently used for tracking the spread of cancer. By avoiding the problems of short lifetimes and specialist handling of radioactive alternatives, as many as a quarter of a million more breast cancer patients in the West could benefit from the 'standard of care' SLNB procedure. With a special nanomagnetic system consisting of the SentiMag instrument and associated Sienna+ tracer, clinicians have available a lower cost, more patient-friendly alternative that greatly improves workflow.


Dr Eric Mayes, Chief Executive Officer of Endomagnetics was asked to give a short presentation to the invited audience. In this Dr Mayes said: "We are naturally delighted to have been selected by this important programme. Since the spin-out from UCL in 2007, we have been well-backed by our investors and have just completed a 160-patient equivalence trial at seven sites in the UK and The Netherlands."


Matthew Rock, part of the founding team of Real Business, said: "Partnering with Wonga, the British Library Business and IP Centre and our panel of expert judges, we've spent six months investigating businesses across the country to select just 50 that we think will be 'challenger' businesses of the future. What's so impressive is to see young firms challenging established industries with a new, often digital, vision. The Wonga Future 50, published with Real Business, illustrates the dynamic change coursing through our economy."


Errol Damelin, Wonga co-founder and Chief Executive Officer, said: "We decided to create the Wonga Future 50, together with Real Business, to help identify, celebrate and, critically, support the most exciting early-stage UK businesses that are launching new products and services to trigger change. We congratulate all 50 businesses on their vision and ambition."


In August 2012, Endomagnetics announced that it had been awarded government funding to explore the clinical feasibility of applying magnetic sentinel lymph node (SLN) detection to melanoma, a significant cancer with more than 116,000 cases per year in the EU and USA alone.

Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo